Osseointegration Implants Market Forecasted to Reach $12.5 Billion by 2023: P&S Market Research
Jan 31, 2018 08:53 am UTC| Business
NEW YORK, Jan. 31, 2018 -- According to the report published by PS Market Research, Osseointegration implants market is forecasted to reach a value of $12.5 billion by 2023, showcasing a CAGR of 4.0% during 2018-2023. ...
Taiwan’s One and Only International Gift & Stationery Show Unveils Creativity and Innovation
Jan 31, 2018 08:52 am UTC| Business
Taipei, Taiwan, Jan. 31, 2018 -- The Taipei International Gift and Stationery Show (Giftionery Taipei 2018), the one and only international gift and stationery show in Taiwan, will roll out its 72nd edition April 19 –...
InterDigital Announces Successful Demonstration of 5G Ready mmW Wireless Crosshaul Transport
Jan 31, 2018 08:30 am UTC| Business
WILMINGTON, Del., Jan. 31, 2018 -- InterDigital, Inc. (NASDAQ:IDCC), a mobile technology research and development company, today announced the successful trial and evaluation of the company’s millimeter wave (mmW)...
Jan 31, 2018 08:05 am UTC| Business
VANCOUVER, British Columbia, Jan. 31, 2018 -- MGX Minerals Inc. (“MGX” or the “Company”) (CSE:XMG) (FKT:1MG) (OTCQB:MGXMF) is pleased to announce the Company’s operating partner (the “Paradox Partner”) has received...
Yandex Provides Update on Timing of Closing of Yandex.Taxi and Uber Transaction
Jan 31, 2018 08:00 am UTC| Business
MOSCOW, Jan. 31, 2018 -- Yandex (NASDAQ:YNDX) today provided an update on the timing of the proposed merger of Yandex.Taxi and the Uber ride-sharing businesses in Russia and neighboring countries. The parties are...
Jan 31, 2018 08:00 am UTC| Business
Tampa, FL, Jan. 31, 2018 -- Cancer informatics and digital pathology workflow solution provider Inspirata®, Inc. announced today that it has acquired Pittsburgh, PA-based Omnyx from GE Healthcare. ...
Sanofi: Sanofi, DNDi seek European Medicines Agency review for sleeping sickness treatment
Jan 31, 2018 07:01 am UTC| Business
Press ReleaseSource: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi, DNDi seek European Medicines Agency review for sleeping sickness treatment Fexinidazole would be first all-oral treatment* under investigation...